Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Puma Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $1.12M in total
Insiders trading
5
Net value
−$1.12M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Puma Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Puma Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wilson Troy EdwardDirector54,750Sep 16, 20262
Cesano AlessandraDirector56,700Sep 16, 20262
Auerbach Alan HPresident and CEO7,261,671Jul 8, 20263
Hunt Douglas MSee Remarks196,841Jul 8, 20263
Nougues Maximo FChief Financial Officer230,637Jul 8, 20263
Moyes Jay MDirector58,322Jun 15, 20261
Miller Michael PatrickDirector81,000Jun 15, 20262
Senderowicz AdrianDirector27,000Jun 15, 20261
Dorval AllisonDirector90,780Jun 15, 20261
Stuglik Brian MDirector113,858Jun 15, 20261
Ludwig Jeffrey JeromeChief Commercial Officer156,792Feb 11, 20250
Wong Alvin FChief Scientific Officer141,241Feb 14, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 18, 2024 (view filing)Jul 171 dayHunt Douglas MSee RemarksSSale−3.64K$3.70−$13.5K−2.7%133.2K after10b5-1
Jul 18, 2024 (view filing)Jul 171 dayLudwig Jeffrey JeromeChief Commercial OfficerSSale−2.60K$3.70−$9.61K−2.1%118.4K after10b5-1
Jul 18, 2024 (view filing)Jul 171 dayNougues Maximo FChief Financial OfficerSSale−4.16K$3.70−$15.4K−2.5%162.5K after10b5-1
Aug 13, 2024 (view filing)Aug 121 dayMiller Michael PatrickDirectorSSale−23.4K$3.49−$81.5K−33.2%47.0K after
Jan 3, 2025 (view filing)Jan 21 dayAuerbach Alan HPresident and CEOSSale−33.8K$3.15−$106.6K−0.5%7.03M after10b5-1
Jan 3, 2025 (view filing)Jan 21 dayHunt Douglas MSee RemarksSSale−8.63K$3.15−$27.2K−6.5%124.6K after10b5-1
Jan 3, 2025 (view filing)Jan 21 dayLudwig Jeffrey JeromeChief Commercial OfficerSSale−9.44K$3.15−$29.7K−8.0%109.0K after10b5-1
Jan 3, 2025 (view filing)Jan 21 dayNougues Maximo FChief Financial OfficerSSale−10.2K$3.15−$32.2K−6.3%152.3K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysCesano AlessandraDirectorSSale−12.2K$3.40−$41.3K−15.0%68.8K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysDorval AllisonDirectorSSale−11.6K$3.40−$39.5K−13.3%75.4K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysMoyes Jay MDirectorSSale−22.0K$3.40−$74.8K−29.2%53.3K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysSenderowicz AdrianDirectorSSale−27.0K$3.40−$91.8K−50.0%27.0K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysStuglik Brian MDirectorSSale−8.10K$3.39−$27.5K−7.9%95.0K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysWilson Troy EdwardDirectorSSale−10.8K$3.40−$36.7K−19.9%43.5K after10b5-1
Jul 10, 2025 (view filing)Jul 8-92 daysAuerbach Alan HPresident and CEOSSale−47.2K$3.53−$166.7K−0.7%7.18M after2 lots10b5-1
Jul 10, 2025 (view filing)Jul 8-92 daysHunt Douglas MSee RemarksSSale−7.82K$3.53−$27.6K−4.5%164.9K after2 lots10b5-1
Jul 10, 2025 (view filing)Jul 8-92 daysNougues Maximo FChief Financial OfficerSSale−9.52K$3.53−$33.7K−4.5%204.2K after2 lots10b5-1
Jul 22, 2025 (view filing)Jul 184 daysCesano AlessandraDirectorSSale−27.0K$3.37−$91.0K−39.2%41.9K after10b5-1
Nov 13, 2025 (view filing)Nov 112 daysMiller Michael PatrickDirectorSSale−20.0K$4.86−$97.2K−27.0%54.0K after
Jan 8, 2026 (view filing)Jan 6-72 daysNougues Maximo FChief Financial OfficerSSale−10.9K$5.86−$64.2K−5.4%193.3K after2 lots10b5-1
Jan 8, 2026 (view filing)Jan 6-72 daysHunt Douglas MSee RemarksSSale−8.99K$5.86−$52.7K−5.5%155.9K after2 lots10b5-1
Jan 8, 2026 (view filing)Jan 6-72 daysAuerbach Alan HPresident and CEOSSale−35.0K$5.86−$204.8K−0.5%7.15M after2 lots10b5-1
Jun 15, 2026 (view filing)Jun 123 daysDorval AllisonDirectorSSale−11.6K$7.20−$83.6K−11.3%90.8K after10b5-1
Jun 15, 2026 (view filing)Jun 123 daysMoyes Jay MDirectorSSale−22.0K$7.22−$158.8K−27.4%58.3K after10b5-1
Jun 15, 2026 (view filing)Jun 123 daysSenderowicz AdrianDirectorSSale−27.0K$7.20−$194.4K−50.0%27.0K after10b5-1
Jun 15, 2026 (view filing)Jun 123 daysStuglik Brian MDirectorSSale−8.10K$7.20−$58.3K−6.6%113.9K after10b5-1
Jun 15, 2026 (view filing)Jun 123 daysWilson Troy EdwardDirectorSSale−10.8K$7.20−$77.8K−15.3%59.8K after10b5-1
Jul 8, 2026 (view filing)8:18 PM ETJul 62 daysNougues Maximo FChief Financial OfficerSSale−9.39K$8.26−$77.6K−3.9%230.6K after10b5-1
Jul 8, 2026 (view filing)8:19 PM ETJul 62 daysHunt Douglas MSee RemarksSSale−8.46K$8.26−$69.9K−4.1%196.8K after10b5-1
Jul 8, 2026 (view filing)8:21 PM ETJul 62 daysAuerbach Alan HPresident and CEOSSale−44.1K$8.26−$364.1K−0.6%7.26M after10b5-1
Sep 16, 2026 (view filing)9:06 PM ETSep 142 daysCesano AlessandraDirectorSSale−62.1K$9.12−$567.0K−52.3%56.7K after10b5-1
Sep 16, 2026 (view filing)9:13 PM ETSep 142 daysWilson Troy EdwardDirectorSSale−5.00K$9.10−$45.5K−8.4%54.8K after10b5-1